Difference between revisions of "Team:Rice/Wet Lab"

Line 50: Line 50:
 
<br><br>
 
<br><br>
 
   <div class="fixed_flyer" id = "sec4" style="position:relative;z-index:4">
 
   <div class="fixed_flyer" id = "sec4" style="position:relative;z-index:4">
     <div class = "h1">Model Building Process</div>
+
     <div class = "h1">Hypoxia induced fluorescence</div>
 
   </div>
 
   </div>
 
   <div class="pagediv">
 
   <div class="pagediv">
 
<br>
 
<br>
 
<div class="para">
 
<div class="para">
<div class="h3">Hypoxia induced fluorescence </div>
+
 
 
<br>
 
<br>
In addition to the induction of iRFP fluorescence by nitric oxide, we also tested the induction of iRFP fluorescence with a hypoxia promoter. We expected iRFP fluorescence to increase with increased hypoxic conditions (less oxygen) when using NarK promoter and fdhf promoters, both characterized as hypoxia-inducible.  
+
In addition to the sinduction of iRFP fluorescence by nitric oxide, we also tested the induction of iRFP fluorescence with a hypoxia promoter. We expected iRFP fluorescence to increase with increased hypoxic conditions (less oxygen) when using NarK promoter and fdhf promoters, both characterized as hypoxia-inducible.  
  
 
Transcription of the fdhf promoter is regulated by an RNA polymerase with sigma factor 54 whose binding is dictated by presence of an additional activator complex consisting of FhlA and formate. Only when the FhlA-formate complex is present will the sigma-54 polymerase initiate transcription. This process is induced by formate, but is also heavily repressed by presence of oxygen, giving it characterization as a hypoxia sensor.  
 
Transcription of the fdhf promoter is regulated by an RNA polymerase with sigma factor 54 whose binding is dictated by presence of an additional activator complex consisting of FhlA and formate. Only when the FhlA-formate complex is present will the sigma-54 polymerase initiate transcription. This process is induced by formate, but is also heavily repressed by presence of oxygen, giving it characterization as a hypoxia sensor.  
  
<br><br>
 
<img src="https://static.igem.org/mediawiki/2016/3/32/Promoter_Strengh_vs_Time_paper.png" style="display: block; margin: auto; width: 80%">
 
<br><br>
 
 
The first step of our model is to describe the rate of change of enzymes based on promoter strength. Here we assumed that the enzyme production rate is directly proportional to strength of the promoter. Therefore, we were able to use a mass-action kinetics equation of promoters to describe the enzyme concentration. The equation is shown below:
 
 
<br><br>
 
<img src="https://static.igem.org/mediawiki/2016/2/28/Protomter_Equations_new.png" style="display: block; margin: auto; width: 25%">
 
<br><br>
 
 
In this equation, Ai is the concentration of enzyme i, ki­ is the production rate of each  enzyme i, kd is the degradation rate of all enzymes, and t is time. By solving this equation, we derived the equation of enzyme concentration against time.
 
 
<br><br>
 
<img src="https://static.igem.org/mediawiki/2016/5/54/Promoter_ODE_new.png" style="display: block; margin: auto; width: 25%">
 
<br><br>
 
 
Since we assumed that the promoter strength is proportional to the promoter concentration, we would use the equation to fit our data using least squares method (Fig. 1).
 
<br><br>
 
<img src="https://static.igem.org/mediawiki/2016/thumb/3/3a/Fitted_Lines_of_Promoter_Strength_vs_Time.png/800px-Fitted_Lines_of_Promoter_Strength_vs_Time.png" style="display: block; margin: auto; width: 80%">
 
<br><br>
 
 
<b>Figure 1.</b> Linear regressions fitted to normalized fluorescence vs time. The circles represent data from Jones et al., 2013. The solid lines are our regression lines. The colors indicate with which promoters the circles and lines correspond.
 
<br><br>
 
In general, the regression lines are able to capture the change of strength of each enzyme over time. In this way, the parameters are determined. The table below lists the parameter values.
 
 
<br><br>
 
<img src="https://static.igem.org/mediawiki/2016/7/7e/Promoter_Strength_Fit_Parameters.png" style="display: block; margin: auto; width: 60%">
 
<br><br>
 
 
<b>Table 1.</b> Parameters realted to promoter strength and degradation of molecules. In the table, ki­ (i = 1,2,3,4,5) are the production rate coefficients of promoter I (i = 1,2,3,4,5), and kd is the degradation rate coefficient of all promoters.
 
 
<br><br>
 
<div class='h3'>2. Modeling the Steady-state Violacein Yield</div>
 
<br>
 
After we finished the regression model of each promoter, we created a second model to describe the violacein biosynthetic pathway. The pathway (Fig. 2) involves five enzyme-catalyzed reactions and one non-enzymatic reaction (Lee et al, 2013).
 
<br><br>
 
<img src= "https://static.igem.org/mediawiki/2016/thumb/2/2f/Violacein_Biosynthetic_Pathway.png/737px-Violacein_Biosynthetic_Pathway.png" style="display: block; margin: auto; width: 80%">
 
<br><br>
 
 
<b>Figure 2.</b> Violacein synthetic pathway. The purple arrows highlight the five enzymatic and one non-enzymatic steps of violacein production from two molecules of tryptophan. The five enzymes are indicated by bolding (VioA, VioB, etc.).
 
 
<br><br>
 
 
The model was developed as three major parts. A pseudocode of this model is provided here.
 
 
<br>
 
 
<b>Define ODE System</b>
 
<ol>
 
<li>Calculate the production and degradation rate of each molecule in the pathway from the concentration of reagents and parameters.</li>
 
<li>Obtain the rate of change of each molecule based on the production and degradation rates.</li>
 
</ol>
 
<b>Solve the System of Nonlinear Equations at Steady State</b>
 
<ol>
 
<li>Solve the system of nonlinear equations at steady state starting at an initial guess X0.</li>
 
<li>Use the result as a new initial guess; repeat the numerical method to solve the system of equations again.</li>
 
<li>Calculate the relative error of each chemical in the new result.</li>
 
<li>If the maximum error is smaller than 0.0001%, output violacein concentration at steady state as the final result.</li>
 
</ol>
 
<b>Optimize Parameters to Fit Experimental Data</b>
 
<ol>
 
<li>Set the initial guess of the parameters.</li>
 
<li>Load the data from literature, which include the choice of promoter for each gene and the corresponding violacein yield determined experimentally.</li>
 
<li>For each promoter selection scenario, pass the promoter types and the temporary parameters to the steady-state model.</li>
 
<li>Obtain the violacein yield predicted by the steady-state model for each promoter selection scenario.</li>
 
<li>Compute the residual sum of squares (RSS) of between the predicted violacein yields and the violacein yields given by experiment.</li>
 
<li>Determine the optimal parameters by minimizing the RSS (least square method).</li>
 
</ol>
 
 
<br>
 
 
Using the principles of mass action kinetics, we derived the system of ODE equations in the model. The equations involves 17 parameters (Table 2). Five parameters (kA, kB, kC, kD and kE) are related to the production rates of the five enzymes, which depend only the strength of the promoter type. Another parameter, kd, is the degradation coefficient of all molecules due to the growth of E.coli. The value of this parameter is fixed  and shown in Table1. In addition to these known parameters, the equations include 11 undetermined parameters related to the reaction rates at specific steps in the violacein synthetic pathway. As described in the pseudocode, we used least square regression to determine the optimal values of these parameters.
 
<br><br>
 
Each one of the11 differential equations describes the rate of change of specific molecule in the system. The equations consider the production, consumption, and degradation rates of the molecules. Degradation of molecules is described by first order decay. Therefore, the rate of degradation of a molecule depends on a degradation constant and the degradation coefficient. The degradation coefficient is identical for all molecules since it only depends on E.coli growth rate.
 
<br><br>
 
<div class="h3"> Differential Equations in the Model</div>
 
  
  
<br><br>
 
<img src="https://static.igem.org/mediawiki/2016/c/cf/Enzyme_Production_Rate.png" style="display: block; margin: auto; width: 80%">
 
<img src="https://static.igem.org/mediawiki/2016/thumb/7/7f/Chemical_Production_Rate_1.png/1200px-Chemical_Production_Rate_1.png" style="display: block; margin: auto; width: 100%">
 
<img src="https://static.igem.org/mediawiki/2016/thumb/f/fd/Chemical_Production_Rate_2.png/1199px-Chemical_Production_Rate_2.png" style="display: block; margin: auto; width: 100%">
 
<br><br>
 
  
 +
</div>
 
<div class="fixed_flyer" id = "sec5" style="position:relative;z-index:5">
 
<div class="fixed_flyer" id = "sec5" style="position:relative;z-index:5">
 
   <div class = "h1">Results</div>
 
   <div class = "h1">Results</div>

Revision as of 03:37, 20 October 2016


           
Overview

Photoacoustic imaging is a technique in which contrast agents absorb photon energy and emit signals that can be analyzed by ultrasound. Currently, photoacoustics is used to image blood vessels because heme is a natural contrast agent found in blood. Photoacoustic imaging also provides a non-invasive alternative to current diagnostic tools used to detect internal tissue inflammation. In previous literature, hypoxia and nitric oxide have both been discovered to molecularly indicate gut inflammation, and iRFP670, 713, anacy and cyan have been found to emit wavelengths that are different from heme and can penetrate tissue with near-infrared wavelengths. Therefore, our goal is to report inflammation and cancer in the gut through photoacoustic imaging of engineered E. coli that express bacterial pigment violacein, as well as near-infrared fluorescent proteins iRFP670 and iRFP713.

Arabinose Induced iRFP 670 and 713 Fluorescence

pBAD is a very well-characterized expression system in E. coli. pBAD normally works by arabinose induction: araC, a constitutively produced transcription regulator, changes form in the presence of arabinose sugar, allowing for the activation of promoter pBAD. Therefore, we formed genetic circuits consisting of the pBAD expression system and iRFP670 and 713 to test the inducibility of our iRFPs.

Nitric-oxide-induced Fluorescence

The next step was to test the nitric oxide induction of iRFP fluorescence. We used a genetic circuit consisting of a constitutive promoter that always expresses Part:BBa_K554003, which encodes for the expression of a SoxR. In the presence of nitric oxide, SoxR changes form to activate the promoter SoxS, which in turn is supposed to activate the expression of the iRFPs. Thus, for the next assay we added DETA/NO, a nitric oxide adduct in the presence of water.


Hypoxia induced fluorescence


In addition to the sinduction of iRFP fluorescence by nitric oxide, we also tested the induction of iRFP fluorescence with a hypoxia promoter. We expected iRFP fluorescence to increase with increased hypoxic conditions (less oxygen) when using NarK promoter and fdhf promoters, both characterized as hypoxia-inducible. Transcription of the fdhf promoter is regulated by an RNA polymerase with sigma factor 54 whose binding is dictated by presence of an additional activator complex consisting of FhlA and formate. Only when the FhlA-formate complex is present will the sigma-54 polymerase initiate transcription. This process is induced by formate, but is also heavily repressed by presence of oxygen, giving it characterization as a hypoxia sensor.
Results

Our model is able to compute the average violacein yields for all the strains tested experimentally, but can not capture the difference of violacein yield with different promoters strengths. The comparison between the violacein yields determined by experiments and those predicted by our model is shown in Figure 3. The optimal parameters determined by the model are listed in Table 2.



Figure 3. VIolacein yield with different promoter combinations. This graph compares the violacein found for various promoter combinations determined by Jones et al., 2013 (shown in blue) with the violacein concentrations that our model predicted for the same promoter combinations. The root-mean-square error (RMSE) is 52.04.



Table 2. Notations of parameters.

Discussion

The current model is not able to show the expected dependence of violacein yield on promoter strength. After reevaluating our assumptions, we identified some potential flaws of the model that might cause the unexpected results.

One of the assumptions from our model is that the rate of production of L-tryptophan is constant and independent of the promoter strength. Jones el al. suggest that the L-tryptophan production rate may be affected by the metabolic burden of the production of the recombinant enzymes (VioA, VioB, etc.). This phenomenon may be caused by the depletion of essential metabolic resource, such as amino acids, mRNA and ATP. Therefore, the L-tryptophan production rate might need to be dependent on enzymes production rates.

Another effect that we didn’t consider is the saturation of the enzymes. To improve our model, we could include these effects by employing Michaelis-Menten Kinetics equations in our next step. Nevertheless, we have been cautious about including this in our model, since increasing the number of parameters, without increasing the number of data points usually causes the overfitting of the model.

Finally, since the violacein pathway has not been fully characterized, it is possible that we ignored some reactions in the complete pathway. Moreover, there may be feedback loops that regulate the pathway. We will need to investigate these possible components and incorporate them into our model if they prove to be present in the pathway.

Conclusion

Here we present a method to fit a model of violacein production in E.coli to experimental data of violacein yield with different promoters using nonlinear regression. Although it fails to calculate the dependence on promoter strength, our model is able predict the average violacein concentration. We expect that small changes on the model, such as including a L-tryptophan production dependence of the metabolic burden, would allow us to successfully predict the violacein production in response to the variation of promoter strength. Once the predictive model is complete, we will be able to find the strains that lead to optimal violacein yield computationally.
References
  1. Carvalho, D. D., Costa, F. T. M., Duran, N., & Haun, M. (2006). Cytotoxic activity of violacein in human colon cancer cells. Toxicology in Vitro, 20(8), 1514–1521.
    http://dx.doi.org/10.1016/j.tiv.2006.06.007
  2. Jones, J. A., Vernacchio, V. R., Lachance, D. M., Lebovich, M., Fu, L., Shirke, A. N., … Koffas, M. A. G. (2015). ePathOptimize: A Combinatorial Approach for Transcriptional Balancing of Metabolic Pathways. Scientific Reports, 5, 11301.
    http://doi.org/10.1038/srep11301
  3. Lee, M. E., Aswani, A., Han, A. S., Tomlin, C. J., & Dueber, J. E. (2013). Expression-level optimization of a multi-enzyme pathway in the absence of a high-throughput assay. Nucleic Acids Research, 41(22), 10668–10678.
    http://doi.org/10.1093/nar/gkt809